EDAP TMS S.A Current Ratio 2010-2024 | EDAP
EDAP TMS S.A current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| EDAP TMS S.A Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-12-31 |
$0.08B |
$0.04B |
1.85 |
| 2024-09-30 |
$0.07B |
$0.03B |
2.18 |
| 2024-06-30 |
$0.07B |
$0.03B |
2.45 |
| 2024-03-31 |
$0.08B |
$0.03B |
2.62 |
| 2023-12-31 |
$0.09B |
$0.03B |
2.84 |
| 2023-09-30 |
$0.09B |
$0.03B |
3.09 |
| 2023-06-30 |
$0.09B |
$0.03B |
3.31 |
| 2023-03-31 |
$0.10B |
$0.03B |
3.40 |
| 2022-12-31 |
$0.10B |
$0.02B |
4.17 |
| 2022-09-30 |
$0.09B |
$0.02B |
4.37 |
| 2022-06-30 |
$0.07B |
$0.02B |
3.58 |
| 2022-03-31 |
$0.08B |
$0.02B |
4.38 |
| 2021-12-31 |
$0.08B |
$0.02B |
3.75 |
| 2021-09-30 |
$0.08B |
$0.02B |
4.34 |
| 2021-06-30 |
$0.08B |
$0.02B |
4.26 |
| 2021-03-31 |
$0.05B |
$0.02B |
2.26 |
| 2020-12-31 |
$0.06B |
$0.03B |
2.11 |
| 2020-09-30 |
$0.05B |
$0.02B |
2.18 |
| 2020-06-30 |
$0.00B |
|
0.00 |
| 2020-03-31 |
$0.00B |
|
0.00 |
| 2019-12-31 |
$0.05B |
$0.02B |
2.41 |
| 2019-09-30 |
$0.00B |
|
0.00 |
| 2019-06-30 |
$0.00B |
|
0.00 |
| 2019-03-31 |
$0.00B |
|
0.00 |
| 2018-12-31 |
$0.05B |
$0.02B |
2.40 |
| 2018-09-30 |
$0.00B |
|
0.00 |
| 2018-06-30 |
$0.05B |
$0.02B |
2.41 |
| 2018-03-31 |
$0.00B |
|
0.00 |
| 2017-12-31 |
$0.05B |
$0.02B |
2.45 |
| 2017-09-30 |
$0.00B |
|
0.00 |
| 2017-06-30 |
$0.04B |
$0.02B |
2.96 |
| 2017-03-31 |
$0.00B |
|
0.00 |
| 2016-12-31 |
$0.05B |
$0.02B |
2.70 |
| 2016-09-30 |
$0.00B |
|
0.00 |
| 2016-06-30 |
$0.05B |
$0.02B |
2.77 |
| 2016-03-31 |
$0.00B |
|
0.00 |
| 2015-12-31 |
$0.04B |
$0.02B |
2.03 |
| 2015-09-30 |
$0.00B |
|
0.00 |
| 2015-06-30 |
$0.03B |
$0.02B |
2.04 |
| 2015-03-31 |
$0.00B |
|
0.00 |
| 2014-12-31 |
$0.04B |
$0.02B |
2.19 |
| 2014-09-30 |
$0.00B |
|
0.00 |
| 2014-06-30 |
$0.04B |
$0.02B |
2.39 |
| 2014-03-31 |
$0.00B |
|
0.00 |
| 2013-12-31 |
$0.03B |
$0.02B |
1.91 |
| 2013-09-30 |
$0.00B |
|
0.00 |
| 2013-06-30 |
$0.03B |
$0.01B |
1.97 |
| 2013-03-31 |
$0.03B |
$0.02B |
1.81 |
| 2012-12-31 |
$0.03B |
$0.02B |
1.89 |
| 2012-09-30 |
$0.03B |
$0.02B |
1.92 |
| 2012-06-30 |
$0.03B |
$0.02B |
1.98 |
| 2012-03-31 |
$0.04B |
$0.02B |
1.95 |
| 2011-12-31 |
$0.04B |
$0.03B |
1.29 |
| 2011-09-30 |
$0.04B |
$0.02B |
2.07 |
| 2011-06-30 |
$0.04B |
$0.02B |
2.04 |
| 2011-03-31 |
$0.04B |
$0.02B |
2.00 |
| 2010-12-31 |
$0.04B |
$0.02B |
2.04 |
| 2010-09-30 |
$0.04B |
$0.02B |
2.09 |
| 2010-06-30 |
$0.04B |
$0.02B |
2.14 |
| 2010-03-31 |
$0.04B |
$0.02B |
2.30 |
| 2009-12-31 |
$0.05B |
$0.02B |
2.19 |
| 2009-09-30 |
$0.04B |
$0.02B |
2.40 |
| 2009-06-30 |
$0.04B |
$0.02B |
2.50 |
| 2009-03-31 |
$0.05B |
$0.02B |
2.41 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$0.080B |
$0.069B |
|
EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors.
|
